ICU Medical Inc (ICUI) is a publicly traded Healthcare sector company. As of May 21, 2026, ICUI trades at $129.31 with a market cap of $3.08B and a P/E ratio of 67.68. ICUI moved +4.60% today. Year to date, ICUI is -10.28%; over the trailing twelve months it is -4.16%. Its 52-week range spans $107.00 to $196.26. Analyst consensus is buy with an average price target of $163.50. Rallies surfaces ICUI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ICUI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ICUI recently traded at $129.31. Market cap is $3.08B. P/E ratio is 67.68. Revenue is $2.16B.
| Metric | Value |
|---|---|
| Price | $129.31 |
| Market Cap | $3.08B |
| P/E Ratio | 67.68 |
| EPS | $1.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $196.26 |
| 52-Week Low | $107.00 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.16B |
| Net Income | $46.34M |
| Gross Margin | 37.93% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.23B | $732.00K | $0.03 |
| 2024 | $2.38B | $-117.69M | $-4.83 |
| 2023 | $2.26B | $-29.66M | $-1.23 |
| 2022 | $2.28B | $-74.29M | $-3.11 |
3 analysts cover ICUI: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $163.50.